Balance Sheet for Boston Scientific Corporation (BSX)

$ 34.41   0.60 (+1.77%) Volume: 26.38m 4:00 PM EST 4-Dec-2020
After Hours:  $ 34.41 0.00 (0.00%) Volume: 8.98m 7:54 PM EST 4-Dec-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 217 146 188 196 319
Restrictable Cash 346 655 827 243 54
Marketable Securities - - - - -
Accounts Receivable 1,828 1,608 1,548 1,472 1,275
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 1,933 1,645 1,548 1,472 1,275
Inventories, Raw Materials 416 306 284 236 208
Inventories, Work in Progress 192 100 110 94 102
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 971 760 685 625 706
Inventories, Other 1,579 1,166 1,077 955 1,016
Inventories, Adjustments & Allowances - - - - -
Inventories 1,579 1,166 1,078 955 1,016
Prepaid Expenses 195 161 66 75 57
Current Deferred Income Taxes - - 216 75 496
Other Current Assets 324 108 942 541 254
Total Current Assets 4,699 4,003 3,822 3,239 3,471
Land and Improvements 117 97 102 91 86
Buildings and Improvement 1,198 1,100 1,120 981 981
Machinery, Furniture and Equipment 3,411 3,224 3,183 2,955 2,793
Construction in Progress 442 319 219 338 202
Fixed Assets, Other 336 - - - -
Fixed Assets, Total 5,504 4,740 4,624 4,365 4,062
Gross Fixed Assets 5,504 4,740 4,624 4,365 4,062
Accumulated Depreciation (3,089) (2,958) (2,928) (2,735) (2,572)
Net Fixed Assets 2,415 1,782 1,696 1,630 1,490
Intangibles 7,886 6,372 5,837 5,883 6,194
Cost in Excess 10,176 7,911 6,998 6,678 6,473
Non-Current Deferred Income Taxes 4,196 87 - - -
Other Non-Current Assets 519 238 688 666 505
Total Non-Current Assets 25,866 16,996 15,220 14,857 14,662
Total Assets 30,565 20,999 19,042 18,096 18,133
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 542 349 530 447 209
Short Term Debt 1,416 2,253 1,801 64 3
Notes Payable - - - - -
Accrued Expenses 1,638 1,535 1,280 1,250 1,197
Accrued Liabilities 1,638 1,535 1,280 1,250 1,197
Deferred Revenues 144 115 - - -
Current Deferred Income Taxes (4,301) (87) 245 (305) (532)
Other Current Liabilities 1,126 1,008 2,043 1,826 1,021
Total Current Liabilities 4,866 5,260 5,654 3,587 2,430
Long Term Debt 8,579 4,771 3,814 5,420 5,674
Deferred Income Tax 595 328 191 18 735
Other Non-Current Liabilities 2,366 1,909 2,370 2,338 2,974
Minority Interest - - - - -
Capital Lease Obligations 282 6 1 1 -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 11,822 7,014 6,376 7,776 9,383
Total Liabilities 16,688 12,274 12,030 11,363 11,813
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 13,877 8,725 7,012 6,733 6,320
Common Par 16 16 16 16 16
Additional Paid in Capital 17,561 17,346 17,161 17,014 16,860
Cumulative Translation Adjustments 142 (53) (32) (79) (54)
Retained Earnings (2,253) (6,953) (8,390) (8,581) (8,927)
Treasury Stock 1,717 1,717 1,717 1,717 1,717
Other Equity Adjustments 270 33 (59) 1 88
Total Capitalization 22,456 13,496 10,826 12,152 11,994
Total Equity 13,877 8,725 7,012 6,733 6,320
Total Liabilities & Shareholder's Equity 30,565 20,999 19,042 18,096 18,133
Cash Flow 4,700 1,671 105 347 (239)
Working Capital (167) (1,257) (1,832) (348) 1,041
Free Cash Flow 1,375 (6) 1,107 596 353
Invested Capital 22,456 13,496 10,826 12,152 11,994
Shares Outstanding - Common Class Only 1,395 1,385 1,373 1,362 1,347
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 1,395 1,385 1,373 1,362 1,347
Total Common Shares Outstanding 1,395 1,385 1,373 1,362 1,347
Treasury Shares 248 248 248 248 248
Basic Weighted Shares Outstanding 1,392 1,381 1,370 1,358 1,341
Diluted Weighted Shares Outstanding 1,411 1,401 1,393 1,377 1,341